Reportable News

Reportable News

Stonegate Capital Partners Updates Its Coverage on ProStar Holdings Inc. (OTCQB: MAPPF) Q4 23
Stonegate Capital Partners Updates Its Coverage on ProStar Holdings Inc. (OTCQX: MAPP.F) Q4 23
Stonegate Capital Partners Updates Coverage On Aemetis, Inc. (Nasdaq: AMTX) Q1 2024
Stonegate Updates Coverage on BFF Bank S.P.A (BIT: BFF) Q1 24
B2i Digital is a Marketing Partner for The Reg A & Crowdfunding Conference and The SPAC Conference in Westchester County, NY
Stonegate Capital Partners Updates Coverage on OppFi, Inc. (NYSE: OPFI) Q1 24
Stonegate Capital Partners Updates Coverage on Electro Optics Systems Holdings Ltd (ASX: EOS) Q1 2024
Stonegate Updates Coverage on Gladstone Commercial Corp. (NASDAQGS: GOOD) Q1 2024
B2i Digital Sponsors and Provides Marketing Support for Maxim Group's Virtual Conference: "Shipping: Insights on Future Demand Trends & Decisions to Build New Ships"
Phizzle Introduces First Data Transformation Engine for BioPharma/GMP Use; Makes it Possible to Harmonize Data into any LIMs from any Instrument
Stonegate Capital Partners Updates Coverage on Forum Energy Technologies, Inc. (NYSE: FET) Q1 24
Omnipoint Technology Revolutionizes Selma, Alabama with Accessible High-Speed Fiber Internet and Comprehensive Digital Services
Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM) 2024 Q1
Stonegate Capital Partners Updates Coverage on Independence Contract Drilling, Inc (NYSE: ICD) Q1 2024
Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
96% of Security Executives Indicate SaaS Security is a High Priority in Valence Security's 2024 State of SaaS Security Report
Stonegate Healthcare Partners Releases Report on Potentially Transformative therapies for Generalized Anxiety Disorder (GAD)
Stonegate Capital Partners Updates Coverage on Alliance Resource Partners, L.P. (NASDAQ: ARLP) 2024 Q1
Stonegate Initiates Coverage on Burcon Nutrascience Corporation (TSX: BU)
InFlectis BioScience awarded $650K grant from the National Multiple Sclerosis Society to advance IFB-048 preclinical development in Multiple Sclerosis; Research to be Performed by Prof. Popko of Northwestern University